{"address1": "855 Oak Grove Avenue", "address2": "Suite 100", "city": "Menlo Park", "state": "CA", "zip": "94025", "country": "United States", "phone": "(650) 606-7910", "website": "https://orukatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23 which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003, focuses on I&I diseases, and inflammatory dermatology conditions; and ORKA-021, an IL-17 inhibitor with the ideal maintenance profile of an IL-23 inhibitors. The company is headquartered in Menlo Park, California.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence Otto Klein Ph.D.", "age": 41, "title": "President, CEO & Director", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 520911, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Quinlan", "age": 61, "title": "General Counsel & Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 310445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joana  Goncalves M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 317986, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arjun  Agarwal CPA", "age": 48, "title": "Senior Vice President of Finance & Treasurer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laura  Sandler", "title": "Senior Vice President of Operations & Boston Site Head", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan  Lada", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Finch", "title": "Vice President of Corporate Development & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajiv  Panwar", "title": "VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joe  Senn Ph.D.", "title": "Senior Vice President of Nonclinical Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://phx.corporate-ir.net/phoenix.zhtml?c=109749&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.26, "open": 10.19, "dayLow": 8.95, "dayHigh": 10.19, "regularMarketPreviousClose": 10.26, "regularMarketOpen": 10.19, "regularMarketDayLow": 8.95, "regularMarketDayHigh": 10.19, "forwardPE": -5.9378886, "volume": 705199, "regularMarketVolume": 705199, "averageVolume": 272713, "averageVolume10days": 248080, "averageDailyVolume10Day": 248080, "bid": 9.39, "ask": 9.63, "bidSize": 1, "askSize": 1, "marketCap": 357931200, "fiftyTwoWeekLow": 8.95, "fiftyTwoWeekHigh": 53.88, "fiftyDayAverage": 11.5232, "twoHundredDayAverage": 25.0045, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -13817724, "profitMargins": 0.0, "floatShares": 23629080, "sharesOutstanding": 37440500, "sharesShort": 1546604, "sharesShortPriorMonth": 1761997, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.041300002, "heldPercentInsiders": 0.03249, "heldPercentInstitutions": 0.85774004, "shortRatio": 6.72, "shortPercentOfFloat": 0.066, "impliedSharesOutstanding": 37440500, "bookValue": 10.13, "priceToBook": 0.94373155, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -70949448, "forwardEps": -1.61, "lastSplitFactor": "1:12", "lastSplitDate": 1725321600, "enterpriseToEbitda": 0.145, "52WeekChange": -0.7548718, "SandP52WeekChange": 0.08089435, "lastDividendValue": 19.356, "lastDividendDate": 1724889600, "quoteType": "EQUITY", "currentPrice": 9.56, "targetHighPrice": 49.0, "targetLowPrice": 20.0, "targetMeanPrice": 39.85714, "targetMedianPrice": 41.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 375648000, "totalCashPerShare": 10.033, "ebitda": -95231992, "totalDebt": 968000, "quickRatio": 28.801, "currentRatio": 28.894, "debtToEquity": 0.253, "operatingCashflow": -63094904, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ORKA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsForward": -1.61, "epsCurrentYear": -2.4, "priceEpsCurrentYear": -3.9833333, "fiftyDayAverageChange": -1.9631996, "fiftyDayAverageChangePercent": -0.17036931, "twoHundredDayAverageChange": -15.444499, "twoHundredDayAverageChangePercent": -0.6176688, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": -6.82261, "regularMarketPrice": 9.56, "shortName": "Oruka Therapeutics, Inc.", "longName": "Oruka Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 871047000000, "preMarketChange": 0.65999985, "preMarketChangePercent": 6.903764, "preMarketPrice": 10.22, "regularMarketChange": -0.6999998, "regularMarketDayRange": "8.95 - 10.19", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 272713, "fiftyTwoWeekLowChange": 0.6100006, "fiftyTwoWeekLowChangePercent": 0.068156496, "fiftyTwoWeekRange": "8.95 - 53.88", "fiftyTwoWeekHighChange": -44.32, "fiftyTwoWeekHighChangePercent": -0.82256866, "fiftyTwoWeekChangePercent": -75.487175, "dividendDate": 1724803200, "earningsTimestamp": 1741295386, "earningsTimestampStart": 1745405940, "earningsTimestampEnd": 1745841600, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743581514, "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_1877171755", "displayName": "Oruka Therapeutics", "trailingPegRatio": null}